A study from researchers at MD Anderson Cancer Center shows the tumor microbiome influences the patient's immune response and survival rate in pancreatic cancer.

The tumour microbiome influences immune response and survival in pancreatic cancer.

A crucial part of our defence against disease, the composition and diversity of the gut microbiome can even affect how cancer immunotherapy works. However, little research has focused on the the tumor microbiota, and how it affects prognosis and survival. Now, a study from researchers at MD Anderson Cancer Center shows the tumor microbiome influences immune response and patient survival in pancreatic cancer, using a … Continue reading The tumour microbiome influences immune response and survival in pancreatic cancer.